Company to send 12 million doses of COVID-19 vaccine adapted to target Omicron.
Moderna is supplying Canada with 12 million COVID-19 shots specifically designed to target the Omicron variant of COVID-19.
Last year, the Canadian government entered into a supply deal with the company for supply of its COVID vaccine for 2022 and 2023.
The contract does allow for access to new adaptations of the vaccine.
Moderna and Canada have agreed to convert six million doses of the company's COVID vaccine, which targets the original virus, to an Omicron-containing bivalent one.
The country will also purchase an addition 4.5 million doses of the Omicron-targeted shot, and is moving forward with a scheduled delivery of 1.5 million shots of the bivalent vaccine.
While existing COVID-19 inoculations continue to provide protections against hospitalization and death, experts say the effectiveness of the vaccine has decreased as the virus has evolved.
Chief Public Health Officer Dr. Theresa Tam says Health Canada is still reviewing submissions for bivalent vaccines from Moderna and Pfizer.

Woodstock Will Name an Official Bird
The Community Challenge Set to Return
STAGES Presents: The Addams Family
Smile Cookies Raise Over $131,300 for Local Charities
Zorra Candidate Profile: Crystal Finch
UPDATE: Tornado Confirmed North of Belmont
Middlesex OPP Charge Woodstock Man
Ingersoll Man is $75,000 Richer
OPP Investigating Alcohol Theft in Ingersoll
Introducing the Heartbeat Lager!
DART Shining a Light on Strangulation
Norwich Candidate Profile - Jim Palmer
Sunrise Farms Expanding into Woodstock
Blandford-Blenheim Candidate Profile - Vanessa Hnat
Brant OPP Briefs - May 20th, 2026
Next Executive Director of United Way Oxford Revealed
Former YMCA Building to House Homelessness Support Centre
Trevor Birtch Trial Daily Recap - Case 2
Tornado & Severe Thunderstorm Warning Issued
PWHL Will Expand to San Jose
Comments
Add a comment